Designed to achieve more, without compromise, the newer, larger syringe size will contain exactly the same trusted RHA® 3 formulation but will give medical aesthetics practitioners an additional 20% more product.
Developed with Teoxane’s proprietary RHA® (Resilient Hyaluronic Acid) technology, Teoxane Teosyal RHA®3 offers a safe, high-performance, cutting-edge dermal filler that is backed by rigorous scientific research and is ideal for use on the Perioral Region (philtrum, oral commissures, lips), Cheeks, Nasolabial Folds, Marionette Lines, Nasojugal Groove, Jawline and Chin.
Created to work with the natural anatomical dynamics of the face to seamlessly follow facial expressions and resist deformations and pressures from skin layers for natural and long-lasting results, Teoxane’s unique RHA® manufacturing technology (preserved network technology) preserves the dynamic long chains of HA naturally found in the skin and requires minimal cross-linking to achieve the desired outcomes, adapting to facial movement and stresses that closely resemble the HA found in the skin. It’s formulated with the following in mind:
The versatility of the TEOSYAL RHA® 3 allows practitioners to confidently inject the right product following Teoxane’s ATP approach (Assessing Ageing and Anatomy) then selecting the most appropriate Technique and Product) to provide natural, tailored results for each patient.
Teoxane UK spokesperson comments “Teoxane Teosyal RHA®3 has long been recognised for its ability to provide natural-looking volume with resilience and flexibility. This redesign brings greater efficiency and more treatment possibilities to support practitioners in delivering tailored treatments for a wider variety of patient needs and facial indications, leading to exceptional outcomes for patients.”
Practitioners wishing to find out more about Teoxane Teosyal RHA®3 should visit www.teoxane.com for further information.